£7.6M
Octopus Ventures led the seed financing, with participation from Horizons Ventures, Verve Ventures, and Air Street Capital, to commercialise live cell imaging technology.
CellVoyant is a biotechnology company developing artificial intelligence platforms to advance novel stem cell therapies.
CellVoyant is an artificial intelligence driven biotechnology company that accelerates the development of novel stem cell therapies. The business combines advanced live cell imaging with proprietary technology to predict stem cell behaviour.
Rafael Carazo Salas
CEO and founder
Octopus Ventures led the seed financing, with participation from Horizons Ventures, Verve Ventures, and Air Street Capital, to commercialise live cell imaging technology.